Adenosine Inhibits Activity of Hypocretin/orexin Neurons by the A1 Receptor in the Lateral Hypothalamus: a Possible Sleep-promoting Effect

Overview

Journal J Neurophysiol

Publisher American Physiological Society

Specialties Neurology
Physiology

Date 2006 Nov 10

PMID 17093123

Citations 81

Authors

Zhong-Wu Liu

Xiao-Bing Gao

Affiliations

Soon will be listed here.

Abstract

Neurons in the lateral hypothalamus (LH) that contain hypocretin/orexin have been established as important promoters of arousal. Deficiencies in the hypocretin/orexin system lead to narcolepsy. The inhibition of hypocretin/orexin neurons by sleep-promoting neurotransmitters has been suggested as one part of the sleep regulation machinery. Adenosine has been identified as a sleep promoter and its role in sleep regulation in the basal forebrain has been well documented. However, the effect of adenosine on arousal-promoting hypocretin/orexin neurons has not been addressed, despite recent evidence that immunocytochemical visualization of adenosine receptors was detected in these neurons. In this study, we examined the hypothesis that adenosine inhibits the activity of hypocretin/orexin neurons by using electrophysiological methods in brain slices from mice expressing green fluorescent protein in hypocretin/orexin neurons. We found that adenosine significantly attenuated the frequency of action potentials without a change in membrane potential in hypocretin/orexin neurons. The adenosine-mediated inhibition arises from depression of excitatory synaptic transmission to hypocretin/orexin neurons because adenosine depresses the amplitude of evoked excitatory postsynaptic potential and the frequency of spontaneous and miniature excitatory postsynaptic currents in these neurons. At the cell body of the hypocretin/orexin neurons, adenosine inhibits voltage-dependent calcium currents without the induction of GIRK current. The inhibitory effect of adenosine is dose dependent, pertussis toxin sensitive, and mediated by A1 receptors. In summary, our data suggest that in addition to its effect in the basal forebrain, adenosine exerts its sleep-promoting effect in the LH by inhibition of hypocretin/orexin neurons.

Citing Articles

Altered ventilatory responses to hypercapnia-hypoxia challenges in a preclinical SUDEP model involve orexin neurons.

Iyer S, Hinman J, Warren T, Matthews S, Simeone T, Simeone K Neurobiol Dis. 2024; 199:106592.

PMID: 38971479 PMC: 11648317. DOI: 10.1016/j.nbd.2024.106592.

Exploring Astrocyte-Mediated Mechanisms in Sleep Disorders and Comorbidity.

Li Y, Que M, Wang X, Zhan G, Zhou Z, Luo X Biomedicines. 2023; 11(9).

PMID: 37760916 PMC: 10525869. DOI: 10.3390/biomedicines11092476.

Does EGFR Signaling Mediate Orexin System Activity in Sleep Initiation?.

Kniazkina M, Dyachuk V Int J Mol Sci. 2023; 24(11).

PMID: 37298454 PMC: 10253995. DOI: 10.3390/ijms24119505.

The stress of losing sleep: Sex-specific neurobiological outcomes.

Wright C, Milosavljevic S, Pocivavsek A Neurobiol Stress. 2023; 24:100543.

PMID: 37252645 PMC: 10209346. DOI: 10.1016/j.ynstr.2023.100543.

Adenosine and P1 receptors: Key targets in the regulation of sleep, torpor, and hibernation.

Ma W, Yuan P, Zhang H, Kong L, Lazarus M, Qu W Front Pharmacol. 2023; 14:1098976.

PMID: 36969831 PMC: 10036772. DOI: 10.3389/fphar.2023.1098976.

References

Chemelli R, Willie J, Sinton C, Elmquist J, Scammell T, Lee C . Narcolepsy in orexin knockout mice: molecular genetics of sleep regulation. Cell. 1999; 98(4):437-51. DOI: 10.1016/s0092-8674(00)81973-x. View

Siegel J . The neurotransmitters of sleep. J Clin Psychiatry. 2004; 65 Suppl 16:4-7. PMC: 8761080. View

Sakurai T, Nagata R, Yamanaka A, Kawamura H, Tsujino N, Muraki Y . Input of orexin/hypocretin neurons revealed by a genetically encoded tracer in mice. Neuron. 2005; 46(2):297-308. DOI: 10.1016/j.neuron.2005.03.010. View

Mileykovskiy B, Kiyashchenko L, Siegel J . Behavioral correlates of activity in identified hypocretin/orexin neurons. Neuron. 2005; 46(5):787-98. PMC: 8281334. DOI: 10.1016/j.neuron.2005.04.035. View

Rajadhyaksha A, Barczak A, Macias W, Leveque J, Lewis S, Konradi C . L-Type Ca(2+) channels are essential for glutamate-mediated CREB phosphorylation and c-fos gene expression in striatal neurons. J Neurosci. 1999; 19(15):6348-59. PMC: 4204489. View

Lee M, Hassani O, Jones B . Discharge of identified orexin/hypocretin neurons across the sleep-waking cycle. J Neurosci. 2005; 25(28):6716-20. PMC: 6725432. DOI: 10.1523/JNEUROSCI.1887-05.2005. View

Lin L, Faraco J, Li R, Kadotani H, Rogers W, Lin X . The sleep disorder canine narcolepsy is caused by a mutation in the hypocretin (orexin) receptor 2 gene. Cell. 1999; 98(3):365-76. DOI: 10.1016/s0092-8674(00)81965-0. View

Henny P, Jones B . Vesicular glutamate (VGlut), GABA (VGAT), and acetylcholine (VACht) transporters in basal forebrain axon terminals innervating the lateral hypothalamus. J Comp Neurol. 2006; 496(4):453-67. PMC: 2423949. DOI: 10.1002/cne.20928. View

Arrigoni E, Chamberlin N, Saper C, McCarley R . Adenosine inhibits basal forebrain cholinergic and noncholinergic neurons in vitro. Neuroscience. 2006; 140(2):403-13. DOI: 10.1016/j.neuroscience.2006.02.010. View

10.

Burdakov D, Jensen L, Alexopoulos H, Williams R, Fearon I, OKelly I . Tandem-pore K+ channels mediate inhibition of orexin neurons by glucose. Neuron. 2006; 50(5):711-22. DOI: 10.1016/j.neuron.2006.04.032. View

11.

Xie X, Crowder T, Yamanaka A, Morairty S, LeWinter R, Sakurai T . GABA(B) receptor-mediated modulation of hypocretin/orexin neurones in mouse hypothalamus. J Physiol. 2006; 574(Pt 2):399-414. PMC: 1817779. DOI: 10.1113/jphysiol.2006.108266. View

12.

Saper C . Staying awake for dinner: hypothalamic integration of sleep, feeding, and circadian rhythms. Prog Brain Res. 2006; 153:243-52. DOI: 10.1016/S0079-6123(06)53014-6. View

13.

Umemiya M, Berger A . Activation of adenosine A1 and A2 receptors differentially modulates calcium channels and glycinergic synaptic transmission in rat brainstem. Neuron. 1994; 13(6):1439-46. DOI: 10.1016/0896-6273(94)90429-4. View

14.

Li J, Perl E . Adenosine inhibition of synaptic transmission in the substantia gelatinosa. J Neurophysiol. 1994; 72(4):1611-21. DOI: 10.1152/jn.1994.72.4.1611. View

15.

Pan W, Osmanovic S, Shefner S . Characterization of the adenosine A1 receptor-activated potassium current in rat locus ceruleus neurons. J Pharmacol Exp Ther. 1995; 273(1):537-44. View

16.

Bekkers J, Stevens C . Quantal analysis of EPSCs recorded from small numbers of synapses in hippocampal cultures. J Neurophysiol. 1995; 73(3):1145-56. DOI: 10.1152/jn.1995.73.3.1145. View

17.

Ulrich D, Huguenard J . Purinergic inhibition of GABA and glutamate release in the thalamus: implications for thalamic network activity. Neuron. 1995; 15(4):909-18. DOI: 10.1016/0896-6273(95)90181-7. View

18.

Satoh S, Matsumura H, Suzuki F, HAYAISHI O . Promotion of sleep mediated by the A2a-adenosine receptor and possible involvement of this receptor in the sleep induced by prostaglandin D2 in rats. Proc Natl Acad Sci U S A. 1996; 93(12):5980-4. PMC: 39174. DOI: 10.1073/pnas.93.12.5980. View

19.

Abel T, Nguyen P, Barad M, Deuel T, Kandel E, Bourtchouladze R . Genetic demonstration of a role for PKA in the late phase of LTP and in hippocampus-based long-term memory. Cell. 1997; 88(5):615-26. DOI: 10.1016/s0092-8674(00)81904-2. View

20.

Porkka-Heiskanen T, Strecker R, Thakkar M, Bjorkum A, Greene R, McCarley R . Adenosine: a mediator of the sleep-inducing effects of prolonged wakefulness. Science. 1997; 276(5316):1265-8. PMC: 3599777. DOI: 10.1126/science.276.5316.1265. View